Antiemetic Fosaprepitant To Remedy Nausea and Vomiting (AFTR NV RCT)
Sponsor: Montefiore Medical Center
A PHASE2/PHASE3 clinical study on Nausea and Nausea and Vomiting, this trial is actively recruiting participants. The trial is conducted by Montefiore Medical Center and has accumulated 8 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE2/PHASE3
-
Jan 2025 — Sep 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Dec 2024 — Jan 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Oct 2024 — Dec 2024 [monthly]
Recruiting PHASE2/PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting PHASE2/PHASE3
▶ Show 3 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2/PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Montefiore Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .